Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Severity of Clinical Illness

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

(2022) Emma K. Accorsi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Estimates of SARS-CoV-2 Omicron Variant Severity in Ontario, Canada

(2022) Ana Cecilia Ulloa et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

(2022) Nicole Wolter et al.   LANCET

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

(2022) Raquel Viana et al.   NATURE

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

(2022) Hung Fu Tseng et al.   NATURE MEDICINE

New Omicron begins to take over, despite late start

(2022) Meredith Wadman   SCIENCE

Omicron: South Africa says fourth wave peak has passed as it lifts curfew

(2022) Elisabeth Mahase   BMJ-British Medical Journal

Viscoelastic Hemostatic Assays: A Primer on Legacy and New Generation Devices

(2022) Oksana Volod et al.   Journal of Clinical Medicine

A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications

(2022) Douglas B. Kell et al.   BIOCHEMICAL JOURNAL

Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study

(2022) Tommy Nyberg et al.   LANCET

Are new Omicron subvariants a threat? Here’s how scientists are keeping watch

(2022) Amy Maxmen   NATURE

Molecular basis of receptor binding and antibody neutralization of Omicron

(2022) Qin Hong et al.   NATURE

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

(2022) Matthew McCallum et al.   SCIENCE

Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients

(2022) Polina Len et al.   Frontiers in Cardiovascular Medicine

Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation

(2022) Connor M. Bunch et al.   Frontiers in Surgery

The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review

(2021) Jan Hartmann et al.   Diagnostics

Prolonged elevation of D‐dimer levels in convalescent COVID‐19 patients is independent of the acute phase response

(2021) Liam Townsend et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein

(2021) Houriiyah Tegally et al.   NATURE

Sixteen novel lineages of SARS-CoV-2 in South Africa

(2021) Houriiyah Tegally et al.   NATURE MEDICINE

Severe COVID-19 and coagulopathy: A systematic review and meta-analysis

(2021) Saikat Mitra et al.   ANNALS ACADEMY OF MEDICINE SINGAPORE

Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications

(2021) Jonathan P. Meizoso et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study

(2021) Stephanie J Salyer et al.   LANCET

Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa

(2021) Susan Engelbrecht et al.   Viruses-Basel

Trauma-induced coagulopathy

(2021) Ernest E. Moore et al.   Nature Reviews Disease Primers

COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

(2021) David M. Smadja et al.   ANGIOGENESIS

SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19

(2021) Lize M. Grobbelaar et al.   BIOSCIENCE REPORTS

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin

(2021) Etheresia Pretorius et al.   Cardiovascular Diabetology

Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)

(2021) Sean Wei Xiang Ong et al.   CLINICAL INFECTIOUS DISEASES

Platelets Contribute to Disease Severity in COVID‐19

(2021) Tessa J. Barrett et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The prognostic value of the SOFA score in patients with COVID-19

(2021) Zheng Yang et al.   MEDICINE

New variants of SARS-CoV-2

(2021) Rafael Cantón et al.   Revista Espanola de Quimioterapia

Elevated Plasma Fibrinogen Is Associated With Excessive Inflammation and Disease Severity in COVID-19 Patients

(2021) Jingrui Sui et al.   Frontiers in Cellular and Infection Microbiology

Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study

(2021) Waasila Jassat et al.   Lancet Global Health

Von Willebrand factor: A key glycoprotein involved in thrombo-inflammatory complications of COVID-19

(2021) Shalki Choudhary et al.   CHEMICO-BIOLOGICAL INTERACTIONS

EVALUATING APACHE AND SOFA SCORING SYSTEMS IN PATIENTS WITH COVID-19

(2021) NIRAJ GOWDA et al.   CHEST

Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity

(2021) Mahda Delshad et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa

(2021) Shirley Collie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show

(2021) Gareth Iacobucci   BMJ-British Medical Journal

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern

(2021) Lixin Lin et al.   Frontiers in Public Health

Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19

(2021) Malgorzata Wygrecka et al.   Blood Advances

Mechanism of thrombocytopenia in COVID-19 patients

(2020) Panyang Xu et al.   ANNALS OF HEMATOLOGY

Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action

(2020) Anastasios Kollias et al.   BRITISH JOURNAL OF HAEMATOLOGY

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

(2020) Claire S Whyte et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Platelet Gene Expression and Function in COVID-19 Patients

(2020) Bhanu Kanth Manne et al.   BLOOD

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

(2020) Giuseppe Lippi et al.   CLINICA CHIMICA ACTA

Thromboelastography Profiles of Critically Ill Patients With Coronavirus Disease 2019

(2020) Eugene Yuriditsky et al.   CRITICAL CARE MEDICINE

Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis

(2020) Patrick M. Moriarty et al.   Current Atherosclerosis Reports

Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes

(2020) Corlia Grobler et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past

(2020) Dimitrios Giannis et al.   JOURNAL OF CLINICAL VIROLOGY

Coagulopathy in COVID‐19

(2020) Toshiaki Iba et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A minimal common outcome measure set for COVID-19 clinical research

(2020) John C Marshall et al.   LANCET INFECTIOUS DISEASES

Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit

(2020) Luca Spiezia et al.   THROMBOSIS AND HAEMOSTASIS

Gingipain R1 and Lipopolysaccharide From Porphyromonas gingivalis Have Major Effects on Blood Clot Morphology and Mechanics

(2020) J. Massimo Nunes et al.   Frontiers in Immunology

Endothelial dysfunction in COVID-19: Current findings and therapeutic implications

(2020) Matthias P. Nägele et al.   ATHEROSCLEROSIS

Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19

(2020) Eugenio D. Hottz et al.   BLOOD

Coagulation and anticoagulation in COVID-19

(2020) Tarik Hadid et al.   BLOOD REVIEWS

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

(2020) Si Zhang et al.   Journal of Hematology & Oncology

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

(2020) Grigoris T. Gerotziafas et al.   THROMBOSIS AND HAEMOSTASIS

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management

(2020) Mouhamed Yazan Abou-Ismail et al.   THROMBOSIS RESEARCH

Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China

(2020) Ying Zou et al.   BioScience Trends

Coagulopathy in patients with COVID-19: A systematic review and meta-analysis

(2020) Xiaolin Zhang et al.   Aging-US

Antibody-induced procoagulant platelets in severe COVID-19 infection

(2020) Karina Althaus et al.   BLOOD

Prevalence of readily detected amyloid blood clots in ‘unclotted’ Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report

(2020) Etheresia Pretorius et al.   Cardiovascular Diabetology

COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart

(2020) Melanie C. Bois et al.   CIRCULATION

Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry

(2020) Sebastian Cremer et al.   Clinical Research in Cardiology

Thrombosis and Coagulopathy in COVID-19

(2020) Juan Esteban Gómez-Mesa et al.   CURRENT PROBLEMS IN CARDIOLOGY

Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation

(2019) Martin J. Page et al.   Scientific Reports

Parkinson’s Disease: A Systemic Inflammatory Disease Accompanied by Bacterial Inflammagens

(2019) Büin Adams et al.   Frontiers in Aging Neuroscience

Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains

(2018) Etheresia Pretorius et al.   Journal of the Royal Society Interface

Blood clot parameters: Thromboelastography and scanning electron microscopy in research and clinical practice

(2017) Etheresia Pretorius et al.   THROMBOSIS RESEARCH

Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation

(2017) Christine Xue et al.   Royal Society Open Science

Novel Diagnostic and Monitoring Tools in Stroke: an Individualized Patient-Centered Precision Medicine Approach

(2016) Sulette de Villiers et al.   Journal of Atherosclerosis and Thrombosis

Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide

(2016) Etheresia Pretorius et al.   Journal of the Royal Society Interface

Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics

(2015) Etheresia Pretorius et al.   Cardiovascular Diabetology

Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)

(2015) Janette Bester et al.   Oncotarget